Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137


microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.

Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R.

Cell Cycle. 2010 Mar 15;9(6):1031-6.


MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R.

Cancer Res. 2009 Oct 1;69(19):7569-76. doi: 10.1158/0008-5472.CAN-09-0529.


MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.

Luan S, Sun L, Huang F.

Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.


Expression level of human miR-34a correlates with glioma grade and prognosis.

Gao H, Zhao H, Xiang W.

J Neurooncol. 2013 Jun;113(2):221-8. doi: 10.1007/s11060-013-1119-1.


MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.

Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin W, Zhang Y.

Cancer Res. 2013 Oct 1;73(19):6046-55. doi: 10.1158/0008-5472.CAN-13-0358.


MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.

Lee HK, Bier A, Cazacu S, Finniss S, Xiang C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, Yalon M, Toren A, Rempel SA, Brodie C.

PLoS One. 2013;8(2):e54652. doi: 10.1371/journal.pone.0054652.


MicroRNA-34a suppresses cell proliferation and induces apoptosis in U87 glioma stem cells.

Sun L, Wu Z, Shao Y, Pu Y, Miu W, Yao J, Wu Y, Yang Z.

Technol Cancer Res Treat. 2012 Oct;11(5):483-90.


MiR-218-5p inhibits the stem cell properties and invasive ability of the A2B5⁺CD133⁻ subgroup of human glioma stem cells.

Wu Z, Han Y, Li Y, Li X, Sun T, Chen G, Huang Y, Zhou Y, Du Z.

Oncol Rep. 2016 Feb;35(2):869-77. doi: 10.3892/or.2015.4418.


MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.

Rani SB, Rathod SS, Karthik S, Kaur N, Muzumdar D, Shiras AS.

Neuro Oncol. 2013 Oct;15(10):1302-16. doi: 10.1093/neuonc/not090.


Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S.

PLoS One. 2011;6(8):e24099. doi: 10.1371/journal.pone.0024099.


MicroRNA-107 inhibits U87 glioma stem cells growth and invasion.

Chen L, Chen XR, Chen FF, Liu Y, Li P, Zhang R, Yan K, Yi YJ, Xu ZM, Jiang XD.

Cell Mol Neurobiol. 2013 Jul;33(5):651-7. doi: 10.1007/s10571-013-9927-6.


MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.

Zhang Y, Schiff D, Park D, Abounader R.

PLoS One. 2014 Mar 12;9(3):e91546. doi: 10.1371/journal.pone.0091546.


MiR-506 functions as a tumor suppressor in glioma by targeting STAT3.

Peng T, Zhou L, Zuo L, Luan Y.

Oncol Rep. 2016 Feb;35(2):1057-64. doi: 10.3892/or.2015.4406.


The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.

Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, Schmittgen T, Jiang J, diPierro CG, Li Y, Chiocca EA, Lee J, Fine H, Abounader R, Lawler S, Purow B.

J Neurosci. 2009 Dec 2;29(48):15161-8. doi: 10.1523/JNEUROSCI.4966-09.2009.


A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

Bu P, Chen KY, Chen JH, Wang L, Walters J, Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, Li J, Yang H, Milsom J, Lee S, Zipfel W, Jin MM, Gümüş ZH, Lipkin SM, Shen X.

Cell Stem Cell. 2013 May 2;12(5):602-15. doi: 10.1016/j.stem.2013.03.002.


miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.

Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, Sander C, Holland EC, Huse JT.

PLoS One. 2012;7(3):e33844. doi: 10.1371/journal.pone.0033844.


MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

de Antonellis P, Medaglia C, Cusanelli E, Andolfo I, Liguori L, De Vita G, Carotenuto M, Bello A, Formiggini F, Galeone A, De Rosa G, Virgilio A, Scognamiglio I, Sciro M, Basso G, Schulte JH, Cinalli G, Iolascon A, Zollo M.

PLoS One. 2011;6(9):e24584. doi: 10.1371/journal.pone.0024584.


CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.

Zheng J, Li XD, Wang P, Liu XB, Xue YX, Hu Y, Li Z, Li ZQ, Wang ZH, Liu YH.

Oncotarget. 2015 Sep 22;6(28):25339-55. doi: 10.18632/oncotarget.4509.


MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

Yang G, Zhang R, Chen X, Mu Y, Ai J, Shi C, Liu Y, Shi C, Sun L, Rainov NG, Li H, Yang B, Zhao S.

J Mol Med (Berl). 2011 Oct;89(10):1037-50. doi: 10.1007/s00109-011-0775-x.


MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.

Cheng Z, Wang HZ, Li X, Wu Z, Han Y, Li Y, Chen G, Xie X, Huang Y, Du Z, Zhou Y.

J Exp Clin Cancer Res. 2015 Mar 26;34:27. doi: 10.1186/s13046-015-0142-9.

Items per page

Supplemental Content

Support Center